Hydrocephalus iPad-App Based Intervention Study

Status Completed

Clinical Trial Summary

This is a pilot study examining the feasibility and efficacy of using Apple iPad applications ("apps") during therapy interventions that target visual motor, visual attention, and visual-spatial reasoning skills in school age children who were previously treated surgically for hydrocephalus. Each subject will participate in an initial assessment and baseline MRI, followed by 6-weeks of iPad app-based interventions, and finally a follow-up assessment and a follow-up MRI.

Clinical Trial Description

Long term visuospatial and visuomotor functional deficits are common in pediatric patients with surgically treated hydrocephalus. The deficits are often mild/moderate at early school age although the gap may widen as the children grow older, leading to increasing adverse impact on school performance and academic achievement. The proposed study will generate initial pilot data for the usage of iPad application based therapy intervention for the treatment of cognitive deficits common to pediatric hydrocephalus. It will help determine the optimal intensity and duration of training protocol adapted for the study. In addition, the sensitivity of neuroimaging (DTI) in response to the therapy will be assessed and validated as a biomarker that reflects the neuroanatomical alterations underpinning the outcome changes. This study will generate the crucial data to support the design of future Phase III clinical trial with the long term goal as changing the current standard of care in order to prevent neurocognitive and sensorimotor deficits before the injury to neural circuitry becomes irreversible. The participants who meet the inclusion criteria and do not opt-out of participation will be called by a study coordinator to ensure eligibility and to schedule the initial assessment date. Participation in this study will include 8-10 study visits. These visits include 2 neuropsychological assessments, 2 MRI visits, and 6 weekly visits during intervention phase. MRI visit can be combined with the neuropsychological assessment visit if possible at both the pre- and post intervention time points. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03595033
Study type	Interventional
Source	Children's Hospital Medical Center, Cincinnati
Contact
Status	Completed
Phase	N/A
Start date	November 24, 2015
Completion date	December 28, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06040697` - Formative Usability Assessment of Wireless Thermal Anisotropy Devices
Terminated	`NCT02408757` - Sonographic Monitoring of Weaning of Cerebrospinal Fluid Drainages
Terminated	`NCT01863381` - Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement	N/A
Completed	`NCT00652470` - A Study Comparing Two Treatments for Infants With Hydrocephalus	Phase 2
Completed	`NCT00196196` - A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.	Phase 3
Terminated	`NCT05501002` - Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus	N/A
Active, not recruiting	`NCT05068128` - Combined Flow and Pressure Study of Craniospinal Dynamic
Completed	`NCT04496414` - Bactiseal Catheter Safety Registry in China
Terminated	`NCT02900222` - Study of Choroid Plexus Cauterization in Patients With Hydrocephalus	N/A
Recruiting	`NCT04099823` - MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics	N/A
Unknown status	`NCT02775136` - An Evaluation of a Non-invasive Brain Monitor	N/A
Completed	`NCT00692744` - Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)	N/A
Recruiting	`NCT04758611` - The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)	N/A
Completed	`NCT04207229` - CERTAS Programmable Valve Registry
Completed	`NCT01976559` - Comparison of Continuous Noninvasive and Invasive Intracranial Pressure Measurement--Celda Infusion Subprotocol	N/A
Terminated	`NCT01973764` - Intraventricular Drain Insertion: Comparison of Ultrasound-guided and Landmark-based Puncture of the Ventricular System	N/A
Completed	`NCT02381977` - Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment	N/A
Recruiting	`NCT06086561` - Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device	N/A
Recruiting	`NCT05910944` - European Study of Prodromal iNPH
Recruiting	`NCT03650101` - Improving Infant Hydrocephalus Outcomes in Uganda

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.